AOTMiT
The Agency for Health Technology Assessment and Tariff System (AOTMiT)
The Agency for Health Technology Assessment and Tariff System (AOTMiT) was established in 2005 as an advisory body to the Ministry of Health. Since 2009 AOTMiT is defined as a legal entity.
The main task of AOTMiT is the preparation for the Minister of Health recommendations on financing all health care services from public funds:
- Drug reimbursement list (available in pharmacy);
- Therapeutic drugs programs (high-cost, innovative drugs) and hospital's chemotherapy drugs list;
- Non– drug technologies (medical devices, surgical procedures etc.);
- National and Local Government Health Care Programs.
The role of AOTMiT is to assess and appraise all medical technologies and services claiming public money founding. Recommendations, statements and opinions issued by AOTMiT are based on additional officially published data, experts opinions, Manufacturer's submission and polish public payer (National Health Fund) evaluation.
Launched in January 2015 The Act of Law (amendment to the Act on healthcare benefits financed from public funds) added new task related to valuation tariff of health care services.
According to Tariff Plan accepted by the Ministry of Health, the contracted products from the list of health care services under the benefit basket will be correspond to relative values (points), not in absolute values (PLN).
Core activities of AOTMiT is also connected with producing health technology assessment (HTA) reports and collect, make available, and disseminate information on HTA results, methodologies, and recommendations generated within or outside of Poland.
The main body of AOTMiT is the President, who leads and oversees all AOTMiT activities. The other most important body within AOTMiT:
- the Transparency Council of AOTMiT (TC) - an advisory, independent body with 20 highly qualified members ,
- the Council for Tariffs Affairs of AOTMiT (CTA) - an advisory, independent body with 10 highly qualified members,
both appointed by Minister of Health.
The role of AOTMiT in decision making process is connected with assessment and appraisal, what is coherent with international standards regarding HTA. Assessment is provided by Analytic Team, using Polish HTA guidelines (first issue 2007) and is related with revision of industry submission.
Appraisal is prepared by TC and President of AOTMiT. It's assessment with added context-specific judgments such as: impact of alternative options, social consequences, organisational implications, relative priorities and wider social and ethical aspects.
In the area of creating the health care services tariff system, the activities of AOTMiT (in close cooperation with the CTA) consist of:
- Establishment of reference product/procedure/treatment/service,
- Establishment the relationship of particular medical product to the reference product/procedure,
- Cost calculation (outliers being rejected),
- Transformation of cost data onto tariff (point).
AOTMiT is a member of the most important health organizations (HTAi, INAHTA, ISPOR, EUnetHTA) and still has been developing international cooperation.
